Vestmark Advisory Solutions, Inc. Biogen Inc. Transaction History

Vestmark Advisory Solutions, Inc.

$2.21 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$222.59 - $267.94 $4,674 - $5,626	-21 Reduced 2.57%	796 $205,000
Q3 2023 Nov 06, 2023	SELL	$253.3 - $285.89 $1.77 Million - $1.99 Million	-6,977 Reduced 89.52%	817 $209,000
Q2 2023 Aug 07, 2023	BUY	$275.25 - $318.06 $41,838 - $48,345	152 Added 1.99%	7,794 $2.22 Million
Q1 2023 May 09, 2023	BUY	$256.56 - $292.34 $13,084 - $14,909	51 Added 0.67%	7,642 $2.12 Million
Q4 2022 Jan 20, 2023	SELL	$252.44 - $306.72 $273,897 - $332,791	-1,085 Reduced 12.51%	7,591 $0
Q3 2022 Nov 03, 2022	BUY	$194.69 - $268.46 $39,911 - $55,034	205 Added 2.42%	8,676 $2.32 Million
Q2 2022 Aug 04, 2022	SELL	$187.54 - $223.02 $48,760 - $57,985	-260 Reduced 2.98%	8,471 $1.73 Million
Q1 2022 Apr 27, 2022	BUY	$193.77 - $244.14 $258,682 - $325,926	1,335 Added 18.05%	8,731 $1.84 Million
Q4 2021 Jan 31, 2022	SELL	$223.92 - $287.77 $297,365 - $382,158	-1,328 Reduced 15.22%	7,396 $1.77 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $15,281 - $19,928	54 Added 0.62%	8,724 $2.47 Million
Q2 2021 Aug 09, 2021	BUY	$259.0 - $414.71 $66,563 - $106,580	257 Added 3.05%	8,670 $3 Million
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $72,642 - $85,104	299 Added 3.68%	8,413 $2.35 Million
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $155,931 - $234,715	-660 Reduced 7.52%	8,114 $1.99 Million
Q3 2020 Oct 19, 2020	SELL	$264.77 - $305.71 $41,039 - $47,385	-155 Reduced 1.74%	8,774 $2.49 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $195,029 - $258,282	-754 Reduced 7.79%	8,929 $2.39 Million
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $2.6 Million - $3.3 Million	9,683 New	9,683 $3.06 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $2.35 Million - $3.25 Million	-10,685 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$217.44 - $243.88 $68,711 - $77,066	-316 Reduced 2.87%	10,685 $2.49 Million
Q2 2019 Aug 20, 2019	SELL	$219.29 - $241.72 $401,081 - $442,105	-1,829 Reduced 14.26%	11,001 $2.57 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $2.78 Million - $4.35 Million	12,830 New	12,830 $3.03 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.

Account